Effects of the 5-HT(2C/2B) receptor agonist 1-(3-chlorophenyl)piperazine on plasma glucose levels of rats

European Journal of Pharmacology

Volumn 307, Issue 1, 1996, Pages 75-80

  Sugimoto, Yumi ^a   Yamada, Jun ^a   Yoshikawa, Tomoko ^a   Horisaka, Kazuyoshi ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

5 HT(2A) receptor; 5 HT(2C 2B) receptor; DOI (1 (2,5 dimethoxy 4 iodophenyl) 2 aminopropane); Hyperglycemia; mCPP (1 (3 chlorophenyl)piperazine)

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; GLUCOSE; HEXAMETHONIUM; KETANSERIN; METHYSERGIDE; RITANSERIN; SEROTONIN 1 ANTAGONIST; SEROTONIN 1C RECEPTOR; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2B RECEPTOR ANTAGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 ANTAGONIST; SEROTONIN RECEPTOR; TROPISETRON; UNCLASSIFIED DRUG; 1-(3-CHLOROPHENYL)PIPERAZINE; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; AMPHETAMINE DERIVATIVE; PIPERAZINE DERIVATIVE; SEROTONIN 2C RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ADRENAL MEDULLECTOMY; ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

AMPHETAMINES; ANIMALS; BLOOD GLUCOSE; HEXAMETHONIUM; HYPERGLYCEMIA; MALE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0030594561     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00189-6     Document Type: Article

References (22)

1. Bagdy, G., K. Szemeredi, B. Kanyicska and D.L. Murphy, 1989a, Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats, J. Pharmacol. Exp. Ther. 250, 72.
2. Bagdy, G., A.E. Calogero, D.L. Murphy and K. Szemeredi, 1989b, Serotonin agonists cause parallel activation of the sympathoad-renomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats, Endocrinology 125, 2664.
3. 2 receptor agonist DOI, Eur. J. Pharmacol. 213, 41.
4. 2 receptor subtypes: a family re-united?, Trends Pharmacol. Sci. 16, 105.
5. Bouhelal, R. and A.K. Mir, 1992, Role of the adrenal medulla in metabolic and pressor effects of 8-OH-DPAT, Br. J. Pharmacol. 105, 159.
6. 1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat, J. Pharmacol. Exp. Ther. 243, 1159.
7. Chaouloff, F., D. Laude and V. Baudrie, 1990a, Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPAT, Eur. J. Pharmacol. 185, 11.
8. 2 receptor agonists DOI and α-methyl-5-HT on plasma glucose and insulin levels in the rat, Eur. J. Pharmacol. 187, 435.
9. 2 receptors are involved in the adrenal catecholamine-releasing and hyperglycemic effects of the 5-hydroxytryptamine indirect agonist d-fenfluramine in the conscious rat, J. Pharmacol. Exp. Ther. 260, 1008.
10. 1C) receptors, J. Pharmacol. Exp. Ther. 242, 552.
11. 1 recognition sites, J. Rec. Res. 8, 59.
12. Hoyer, D., D.E. Clarke, J.R. Fozard, P.R. Hartig, G.R. Martin, E.J. Mykecharane, P.R. Saxena and P.P.A. Humphrey, 1994, International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin), Pharmacol. Rev. 46, 157.
13. Humphrey, P.P.A., P. Hartig and D. Hoyer, 1993, A proposed new nomenclature for 5-HT receptors, Trends Pharmacol. Sci. 14, 233.
14. 1C receptors, Br. J. Pharmacol. 94, 137.
15. 1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia, Br. J. Pharmacol. 103, 2016.
16. 1C receptor antagonists, Eur. J. Pharmacol. 164, 445.
17. 2C/2B receptor antagonist, Br. J. Pharmacol. 111, 797.
18. Klodzinska, A. and E. Chojnacka-Wójcik, 1992, Hyperthermia induced by m-trifluoromethylphenylpiperazine (TFMPP) or m-chlorophenylpiperazine (m-CPP) in heat-adapted rats, Psychopharmacology 109, 466.
19. Maj, J. and A. Lewandowska, 1980, Central serotoninmimetic action of phenylpiperazines, Pol. J. Pharmacol. Pharm. 32, 495.
20. Murphy, D.L., K.P. Lesch, C.S. Aulakh and T.A. Pigott, 1991, Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans, Pharmacol. Rev. 43, 527.
21. Simansky, K.J. and L.E. Schechter, 1987, Dissociation of the behavioral properties of 1-arylpiperazines in models for central serotonergic stimulation in rodents, Fed. Proc. 46, 966.
22. 1A receptor agonist buspirone on the blood glucose and pancreatic hormones in rats, Jpn. J. Pharmacol. 60, 145.